SAWAI PHARMACEUTICAL CO., LTD.
沢井製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4555
FY2019 · 2020-03-31
| Gross margin | 40.3% |
| Operating margin | 14.7% |
| Net margin | 10.6% |
| Return on equity | 9.2% |
| Return on assets | 5.0% |
| Revenue growth (YoY) | -1.0% |
| EPS (basic) | ¥440.37 |
| EPS growth (YoY) | -0.5% |
| Current ratio | — |
| Equity ratio | 54.6% |
| Book value / share | ¥4,535.55 |
| Free cash flow | 24,755 M |